Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and Cancer of Ovary

oxazoles has been researched along with Cancer of Ovary in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19906 (37.50)18.7374
1990's1 (6.25)18.2507
2000's0 (0.00)29.6817
2010's7 (43.75)24.3611
2020's2 (12.50)2.80

Authors

AuthorsStudies
Bian, J; Cao, H; Cao, L; Chen, K; Ding, H; Guang, Y; Hou, Z; Li, P; Li, Y; Li, Z; Luo, C; Mei, L; Pei, Y; Xu, W; Yang, Y; Zhang, T; Zhou, B1
Ameratunga, M; Aspegren, J; Bono, P; Braña, I; de Bono, JS; Korjamo, T; Plummer, R; Postel-Vinay, S; Snapir, A1
Moehle, C; Ortmann, O; Schüler-Toprak, S; Skrzypczak, M; Treeck, O1
Beaudoin, JJ; Bludau, H; Jordan, R; Kabanov, AV; Makita, N; Min, Y; Sokolsky, M; Vinod, N; Wan, X; Wang, A1
Allingham, JS; Craig, AW; Evans, PA; Nersesian, S; Newsted, D; Shah, K; Williams, R; Young, S1
Agadjanian, H; Allen, JR; Aspuria, PJ; Cheon, DJ; Funari, V; Greenberg, D; Karlan, BY; Mizuno, T; Orsulic, S; Spiteri, E; Spurka, L; Taylor-Harding, B; Walsh, C; Wang, Q; Wiedemeyer, WR1
Chen, H; Ding, HF; Dong, Z; Fang, D; Huang, S; Jing, Q; Lu, Y; Su, SB; Yang, L1
Alakhova, D; Bludau, H; Darr, DB; Dobrovolskaia, MA; He, Z; Jordan, R; Kabanov, AV; Li, Z; Luxenhofer, R; Montgomery, SA; Perou, CM; Schulz, A; Sokolsky, M; Stern, ST; Wan, X; Yuan, H1
Cholujova, D; Csaderova, L; Fojtu, M; Gronesova, P; Hudecova, S; Kopacek, J; Krizanova, O; Markova, J; Novakova, M; Pastorek, M; Pastorekova, S; Sedlak, J; Simko, V; Sirova, M; Stracina, T; Svastova, E1
Carl, PL; Chakravarty, PK; Katzenellenbogen, JA; Weber, MJ1
Bonavida, B; Uslu, R1
Ansbacher, R1
Cox, PJ; Levin, L1
Bergeron, R; Honeysett, JM; Taetle, R1
Davis, TE; Earhart, RH; Faraggi, D; Khandekar, JD; Schinella, RA1
Blessing, JA; Buchsbaum, HJ; DiSaia, PJ; McGuire, WP1

Trials

2 trial(s) available for oxazoles and Cancer of Ovary

ArticleYear
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
    British journal of cancer, 2020, Volume: 123, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Biological Availability; Blood Platelets; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Fatigue; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms; Oxazoles; Prostatic Neoplasms, Castration-Resistant; Proteins; Pyridines; Quinolines; Sarcoma; Small Cell Lung Carcinoma; Young Adult

2020
Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
    Investigational new drugs, 1989, Volume: 7, Issue:2-3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Infusions, Intravenous; Isoxazoles; Middle Aged; Ovarian Neoplasms; Oxazoles

1989

Other Studies

14 other study(ies) available for oxazoles and Cancer of Ovary

ArticleYear
Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer.
    Bioorganic & medicinal chemistry, 2021, 12-15, Volume: 52

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; Molecular Structure; Ovarian Neoplasms; Oxazoles; p300-CBP Transcription Factors; Spiro Compounds; Structure-Activity Relationship

2021
Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.
    BMC cancer, 2017, May-08, Volume: 17, Issue:1

    Topics: Androstane-3,17-diol; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor beta; Estrogens; Female; Flavanones; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Oxazoles; Phenols

2017
Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments.
    Biomaterials, 2019, Volume: 192

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Drug Carriers; Drug Liberation; Female; Humans; Mice, Nude; Micelles; Ovarian Neoplasms; Oxazoles; Paclitaxel

2019
Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and Metastasis.
    Scientific reports, 2018, 11-22, Volume: 8, Issue:1

    Topics: Ado-Trastuzumab Emtansine; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Female; Humans; Lung Neoplasms; Marine Toxins; Maytansine; Mice; Ovarian Neoplasms; Oxazoles; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays

2018
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS.
    Oncotarget, 2015, Jan-20, Volume: 6, Issue:2

    Topics: Animals; Cyclin E; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; E2F Transcription Factors; Female; Humans; Mice; Mice, Nude; Oncogene Proteins; Ovarian Neoplasms; Oxazoles; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; Proto-Oncogene Proteins p21(ras); Pyridines; Random Allocation; ras Proteins; Receptor Protein-Tyrosine Kinases; Signal Transduction; Thiazoles; Transcription, Genetic; Xenograft Model Antitumor Assays

2015
Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.
    Oncotarget, 2015, Aug-28, Volume: 6, Issue:25

    Topics: Animals; Apoptosis; CDC2 Protein Kinase; Cell Line, Tumor; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Oncogene Proteins; Ovarian Neoplasms; Oxazoles; RNA, Small Interfering; Thiazoles; Triazoles

2015
A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity.
    Biomaterials, 2016, Volume: 101

    Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Carriers; Female; Humans; Mice; Mice, Inbred BALB C; Micelles; Ovarian Neoplasms; Oxazoles; Paclitaxel

2016
Sulforaphane-induced apoptosis involves the type 1 IP3 receptor.
    Oncotarget, 2016, Sep-20, Volume: 7, Issue:38

    Topics: Animals; Anticarcinogenic Agents; Antioxidant Response Elements; Apoptosis; Calcium; Cell Line, Tumor; Cell Nucleus; Endoplasmic Reticulum; Female; Heme Oxygenase-1; Humans; Inositol 1,4,5-Trisphosphate Receptors; Isothiocyanates; Kruppel-Like Transcription Factors; Macrocyclic Compounds; Mice; Mice, Nude; Mitochondria; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Ovarian Neoplasms; Oxazoles; Oxidative Stress; Reactive Oxygen Species; Sulfoxides; Transcriptional Activation; Up-Regulation; Xenograft Model Antitumor Assays

2016
Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard.
    Journal of medicinal chemistry, 1983, Volume: 26, Issue:5

    Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Survival; Cell Transformation, Neoplastic; Female; Fibrinolysin; Isoxazoles; Melanoma; Mice; Nitrogen Mustard Compounds; Oligopeptides; Ovarian Neoplasms; Oxazoles; Plasminogen Activators

1983
Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
    Cancer, 1996, Feb-15, Volume: 77, Issue:4

    Topics: Antineoplastic Agents; Antioxidants; Butylated Hydroxyanisole; Cell Line; Cell Survival; Cisplatin; Drug Synergism; Electron Transport Complex II; Female; Free Radicals; Humans; Mitochondria; Multienzyme Complexes; NAD(P)H Dehydrogenase (Quinone); Ovarian Neoplasms; Oxazoles; Oxidoreductases; Oxygen Consumption; Pyrones; Succinate Dehydrogenase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1996
Treatment of endometriosis with Danazol.
    American journal of obstetrics and gynecology, 1975, Jan-15, Volume: 121, Issue:2

    Topics: Adult; Castration; Endometriosis; Ethisterone; Fallopian Tubes; Female; Humans; Hysterectomy; Isoxazoles; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Oxazoles; Uterine Neoplasms

1975
Novel metabolic products of cyclophosphamide in human urine.
    Biochemical pharmacology, 1975, Jun-15, Volume: 24, Issue:11-12

    Topics: Animals; Carcinoma; Carcinoma 256, Walker; Cells, Cultured; Chromatography, Thin Layer; Cyclophosphamide; Female; Humans; Mass Spectrometry; Nitrogen Mustard Compounds; Ovarian Neoplasms; Oxazoles; Phosphorus Radioisotopes; Piperazines

1975
Combination iron depletion therapy.
    Journal of the National Cancer Institute, 1989, Aug-16, Volume: 81, Issue:16

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chelating Agents; Drug Screening Assays, Antitumor; Female; Gallium; Granulocytes; Hematopoietic Stem Cells; Humans; Immunoglobulin A; Iron Deficiencies; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Macrophages; Ovarian Neoplasms; Oxazoles; Receptors, Transferrin; Tumor Cells, Cultured

1989
Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    Investigational new drugs, 1986, Volume: 4, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Oxazoles

1986